Our Research Publications
Updated November 2023
Pagination
- Page 1
- Next page
Title | Authors | Year | Journal | Link to Article | Intended Audience Sort ascending | Purpose |
---|---|---|---|---|---|---|
Factor XIa-specific aptamers | Sheffield WP, Donkor DA | 2017 | European Patent Office | View Factor XIa-specific aptamers | Industry | New or improved product or process |
Validation of administrative database codes for acute kidney injury in kidney transplant recipients | Molnar AO, van Walraven C, McArthur E, Fergusson D, Garg AX, Knoll G | 2016 | Can J Kidney Health Dis | View Validation of administrative database codes for acute kidney injury in kidney transplant recipients | Regulators | New or improved product or process |
Exploring the reasons for low pertussis vaccine effectiveness in Ontario, Canada, 2006–2008: a Canadian Immunization Research Network study | Hughes SL, Kwong JC, Schwartz KL, Chen C, Johnson C, Li Y, Marchand-Austin A, Bolotin S, Jamieson FB, Drews SJ, Russell ML, Svenson LW, Mahmud SM, Crowcroft NS | 2022 | Can J Public Health | View Exploring the reasons for low pertussis vaccine effectiveness in Ontario, Canada, 2006–2008: a Canadian Immunization Research Network study | Regulators | Clinical research |
Enlargement of the WHO international repository for platelet transfusion-relevant bacteria reference strains | Spindler-Raffel E, Benjamin RJ, McDonald CP, Ramirez-Arcos S, Aplin K, Bekeredjian-Ding I, de Korte D, Gabriel C, Gathof B, Hanschmann KM, Hourfar K, Ingram C, Jacobs MR, Keil SD, Kou Y, Lambrecht B, Marcelis J, Mukhtar Z, Nagumo H, Niekerk T, Rojo J, Marschner S, Satake M, Seltsam A, Seifried E, Sharafat S, Stormer M, Sussner S, Wagner SJ, Yomtovian R | 2017 | Vox Sang | View Enlargement of the WHO international repository for platelet transfusion-relevant bacteria reference strains | Regulators | Benchmarking and standard setting |
The Market in Noninvasive Prenatal Tests and the Message to Consumers: Exploring Responsibility | Holloway K, Simms N, Hayeems RZ, Miller FA | 2022 | Hastings Cent Rep | View The Market in Noninvasive Prenatal Tests and the Message to Consumers: Exploring Responsibility | Regulators | Ethical, legal and social implications research |
Bacterial growth in red blood cell units exposed to uncontrolled temperatures: challenging the 30-minute rule | Ramirez-Arcos S, Perkins H, Kou Y, Mastronardi C, Kumaran D, Taha M, Yi QL, McLaughlin N, Kahwash E, Lin Y, Acker J | 2013 | Vox Sang | View Bacterial growth in red blood cell units exposed to uncontrolled temperatures: challenging the 30-minute rule | Regulators | New or improved product or process |
Evaluating the 4-hour and 30-minute rules: effects of room temperature exposure on red blood cell quality and bacterial growth | Ramirez-Arcos S, Mastronardi C, Perkins H, Kou Y, Turner T, Mastronardi E, Hansen A, Yi QL, McLaughlin N, Kahwash E, Lin Y, Acker J | 2013 | Transfusion | View Evaluating the 4-hour and 30-minute rules: effects of room temperature exposure on red blood cell quality and bacterial growth | Regulators | New or improved product or process |
Early warning and rapid public health response to prevent COVID-19 outbreaks in long-term care facilities (LTCF) by monitoring SARS-CoV-2 RNA in LTCF site-specific sewage samples and assessment of antibodies response in this population: prospective study protocol | Lee BE, Sikora C, Faulder D, Risling E, Little LA, Qiu Y, Gao T, Bulat R, Craik S, Hrudey SE, Ohinmaa A, Estabrooks CA, Gingras A-C, Charlton C, Kim J, Wood H, Robinson A, Kanji JN, Zelyas N, O’Brien SF, Drews S, Pang X-L | 2021 | BMJ Open | View Early warning and rapid public health response to prevent COVID-19 outbreaks in long-term care facilities (LTCF) by monitoring SARS-CoV-2 RNA in LTCF site-specific sewage samples and assessment of antibodies response in this population: prospective study protocol | Regulators | New or improved product or process |
ResearchUnit: Whole blood: longer holding times before leukoreduction may be a safe to explore option | Chen ZY | 2022 | Blood.ca website | View ResearchUnit: Whole blood: longer holding times before leukoreduction may be a safe to explore option | Regulators | New or improved product or process |
Concentré de recherche: Le risque de transmission du VIH est demeuré inchangé avec l’élargissement des critères d’admissibilité aux hommes gais, bisexuels et autres hommes ayant des rapports sexuels avec d’autres hommes | Walsh G | 2022 | Blood.ca website | View Concentré de recherche: Le risque de transmission du VIH est demeuré inchangé avec l’élargissement des critères d’admissibilité aux hommes gais, bisexuels et autres hommes ayant des rapports sexuels avec d’autres hommes | Regulators | MSM research |
ResearchUnit: Risk of HIV did not change with expanding eligibility criteria for gay, bisexual and other men who have sex with men | Walsh G | 2022 | Blood.ca website | View ResearchUnit: Risk of HIV did not change with expanding eligibility criteria for gay, bisexual and other men who have sex with men | Regulators | MSM research |
HIV incidence and compliance with deferral criteria over three progressively shorter time deferrals for men who have sex with men in Canada | Caffrey N, Goldman M, Osmond L, Yi Q-L, Fan W, O'Brien SF | 2022 | Transfusion | View HIV incidence and compliance with deferral criteria over three progressively shorter time deferrals for men who have sex with men in Canada | Regulators | MSM research |
Blood shortages planning in Canada: The National Emergency Blood Management Committee experience during the first 6 months of the COVID-19 pandemic | Prokopchuk-Gauk O, Petraszko T, Nahirniak S, Doncaster C, Levy I | 2021 | Transfusion | View Blood shortages planning in Canada: The National Emergency Blood Management Committee experience during the first 6 months of the COVID-19 pandemic | Regulators | Benchmarking and standard setting |
Regulatory decisions pertaining to aprotinin may be putting patients at risk | Hebert PC, Fergusson DA, Hutton B, Mazer CD, Fremes S, Blajchman M, MacAdams C, Wells G, Robblee J, Bussieres J, Teoh K | 2014 | CMAJ | View Regulatory decisions pertaining to aprotinin may be putting patients at risk | Regulators | Other |
The importance of evaluating differences in HES formulations used in hematopoietic progenitor cell cryopreservation | Halpenny M, William N, Elmoazzen H, Giulivi A, Martin L, Perron D, Bredeson C, Hamelin L, Huebsch L, Yang L, Birch P, Acker JP | 2021 | Cytotherapy | View The importance of evaluating differences in HES formulations used in hematopoietic progenitor cell cryopreservation | Blood operators | New or improved product or process |
Whole blood donor return rates after deferral for tattooing or body piercing—Survey across blood donation services: The BEST collaborative study | Quee F, O'Brien SF, Prinsze F, Steele WR, Grégoire Y, Cutajar A, Wendel S, Compernolle V, Goldman M, van den Hurk K, Biomedical Excellence for Safer Transfusion Collaborative | 2022 | Vox Sang | View Whole blood donor return rates after deferral for tattooing or body piercing—Survey across blood donation services: The BEST collaborative study | Blood operators | Benchmarking and standard setting |
Sommaire des réactions transfusionnelles indésirables | Yan M | 2022 | Blood.ca website | View Sommaire des réactions transfusionnelles indésirables | Blood operators | Benchmarking and standard setting |
Coagulation factor content of plasma produced from whole blood stored for 24 hours at ambient temperature: results from an international multicenter BEST Collaborative study | Cardigan R, Van der Meer PF, Pergande C, Cookson P, Baumann-Baretti B, Cancelas JA, Devine D, Gulliksson H, Vassallo R, de Wildt-Eggen J | 2011 | Transfusion | View Coagulation factor content of plasma produced from whole blood stored for 24 hours at ambient temperature: results from an international multicenter BEST Collaborative study | Blood operators | New or improved product or process |
Exploring resource allocation and alternate clinic accessibility landscapes for improved blood donor turnout | Paez A, Esita J, Newbold KB, Heddle NM, Blake JT | 2013 | Appl Geogr | View Exploring resource allocation and alternate clinic accessibility landscapes for improved blood donor turnout | Blood operators | New or improved product or process |
Impact of a 5-year deferral from blood donation for men who have sex with men | O'Brien SF, Osmond L, Fan W, Yi Q-L, Goldman M | 2015 | Transfusion | View Impact of a 5-year deferral from blood donation for men who have sex with men | Blood operators | Benchmarking and standard setting |
Stepping Stones or Second Class Donors?: a qualitative analysis of gay, bisexual, and queer men's perspectives on plasma donation policy in Canada | Grace D, Gaspar M, Klassen B, Lessard D, Anand P, Brennan DJ, Lachowsky N, Adam BD, Cox J, Lambert G, Jollimore J, Hart TA | 2021 | BMC Public Health | View Stepping Stones or Second Class Donors?: a qualitative analysis of gay, bisexual, and queer men's perspectives on plasma donation policy in Canada | Blood operators | MSM research |
An expanded role for blood donor emerging pathogens surveillance | O’Brien SF, Goldman M, Drews S | 2023 | CMAJ | View An expanded role for blood donor emerging pathogens surveillance | Blood operators | New or improved product or process |
Impact of technical and assay variation on reporting of hemolysis in stored red blood cell products | Almizraq RJ, Yi QL, Acker JP | 2017 | Clinica Chimica Acta | View Impact of technical and assay variation on reporting of hemolysis in stored red blood cell products | Blood operators | New or improved product or process |
Lipoprotein enrichment in orange insoluble particulate matter reproducibly appearing in cryoprecipitate | Sheffield WP, Bhakta V, Trigatti B, Jenkins C | 2011 | Vox Sang | View Lipoprotein enrichment in orange insoluble particulate matter reproducibly appearing in cryoprecipitate | Blood operators | Basic research |
Vox Sanguinis International Forum on platelet cryopreservation | Cohn CS, Dumont LJ, Lozano M, Marks DC, Johnson L, Ismay S, Bondar N, T'Sas F, Yokoyama APH, Kutner JM, Acker JP, Bohonek M, Sailliol A, Martinaud C, Poglod R, Antoniewicz-Papis J, Lachert E, Pun PBL, Lu J, Cid J, Guijarro F, Puig L, Gerber B, Alberio L, Schanz U, Buser A, Noorman F, Zoodsma M, van der Meer PF, de Korte D, Wagner S, O'Neill M | 2017 | Vox Sang | View Vox Sanguinis International Forum on platelet cryopreservation | Blood operators | New or improved product or process |
Concentré de recherche: Des questions de sélection fondées sur le comportement sexuel?: comprendre et atténuer le?malaise des donneurs | Woo H | 2022 | Blood.ca website | View Concentré de recherche: Des questions de sélection fondées sur le comportement sexuel?: comprendre et atténuer le?malaise des donneurs | Blood operators | MSM research |
A generic modelling framework to evaluate network blood management policies: The Canadian Blood Services experience | Blake JT, Hardy M | 2014 | Oper Res Health Care | View A generic modelling framework to evaluate network blood management policies: The Canadian Blood Services experience | Blood operators | New or improved product or process |
Evaluation of selective screening of donors for antibody to Trypanosoma cruzi: seroprevalence of donors who answer no to risk questions | O'Brien SF, Scalia V, Goldman M, Fan W, Yi QL, Huang M, Ndao M, Fearon MA | 2014 | Transfusion | View Evaluation of selective screening of donors for antibody to Trypanosoma cruzi: seroprevalence of donors who answer no to risk questions | Blood operators | New or improved product or process |
Iron depletion and routine ferritin measurement in blood donors | Goldman M | 2015 | ISBT Sci Ser | View Iron depletion and routine ferritin measurement in blood donors | Blood operators | New or improved product or process |
Making good policy decisions: a discipline we cannot afford to ignore | Leach Bennett J | 2015 | Transfusion | View Making good policy decisions: a discipline we cannot afford to ignore | Blood operators | Other |
The epidemiology of imported malaria and transfusion policy in five non-endemic countries | O'Brien SF, Delage G, Seed CR, Pillonel J, Fabra CC, Davison K, Kitchen A, Steele WR, Leiby DA | 2015 | Transfus Med Rev | View The epidemiology of imported malaria and transfusion policy in five non-endemic countries | Blood operators | Other |
HIV Risk Factors | Goldman M | 2019 | Screening Blood Donors with the Donor History Questionnaire | View HIV Risk Factors | Blood operators | Benchmarking and standard setting |
Trends in platelet distributions from 2008 to 2017: a survey of twelve national and regional blood collectors | Yazer MH, Shaz B, Seheult JN, Apelseth TO, de Korte D, Devin G, Devine D, Doncaster C, Field S, Flanagan P, Huet J, Mendrone Jr A, O’Brien C, Pink J, Rashleigh M, Shinar E, Takanashi M, Tian E, Tiberghien P, van den Berg K, Schmitt C | 2020 | Vox Sang | View Trends in platelet distributions from 2008 to 2017: a survey of twelve national and regional blood collectors | Blood operators | Benchmarking and standard setting |
Research partnerships between blood services and public health authorities: An international, cross-sectional survey | Lewin A, Osiowy C, Erikstrup C, Custer B, Renaud C, Tiberghien P, Russell A, Lieshout-Krikke R, O'Brien SF, the Surveillance Risk Assessment Policy Sub-group of the ISBT Transfusion Transmitted Infectious Diseases Working Party | 2022 | Vox Sang | View Research partnerships between blood services and public health authorities: An international, cross-sectional survey | Blood operators | Benchmarking and standard setting |
Development of a quality monitoring program for platelet components: a report of the first four years' experience at Canadian Blood Services | Levin E, Jenkins C, Culibrk B, Gyongyossy-Issa MIC, Serrano K, Devine DV | 2012 | Transfusion | View Development of a quality monitoring program for platelet components: a report of the first four years' experience at Canadian Blood Services | Blood operators | New or improved product or process |
Frequency and risk factors for donor reactions in an anonymous blood donor survey | Goldman M, Osmond L, Yi QL, Cameron-Choi K, O'Brien SF | 2012 | Transfusion | View Frequency and risk factors for donor reactions in an anonymous blood donor survey | Blood operators | Other |
Prevention of transfusion-transmitted cytomegalovirus (CMV) infection: Standards of care | Lieberman L, Devine DV, Reesink HW, Panzer S, Wong J, Raison T, Benson S, Pink J, Leitner GC, Horvath M, Compernolle V, Scuracchio PSP, Wendel S, Delage G, Nahirniak S, Dongfu X, Krusius T, Juvonen E, Sainio S, Cazenave JP, Guntz P, Kientz D, Andreu G, Morel P, Seifried E, Hourfar K, Lin CK, O'Riordan J, Raspollini E, Villa S, Rebulla P, Flanagan P, Teo D, Lam S, Ang AL, Lozano M, Sauleda S, Cid J, Perreira A, Ekermo B, Niederhauser C, Waldvogel S, Fontana S, Desborough MJ, Pawson R, Li M, Kamel H, Busch M, Qu L, Triulzi D | 2014 | Vox Sang | View Prevention of transfusion-transmitted cytomegalovirus (CMV) infection: Standards of care | Blood operators | Benchmarking and standard setting |
Standardization of CD62P measurement: results of an international comparative study | Levin E, Serrano K, Devine DV, for the Biomedical Excellence for Safer Transfusion Collaborative | 2013 | Vox Sang | View Standardization of CD62P measurement: results of an international comparative study | Blood operators | Benchmarking and standard setting |
The use of the electronic (computer) cross-match | Reesink HW, Davis K, Wong J, Schwartz DW, Mayr WR, Devine DV, Georgsen J, Chiaroni J, Ferrera V, Roubinet F, Lin CK, O'Donovan B, Fitzgerald JM, Raspollini E, Villa S, Rebulla P, Makino S, Gounder D, Safwenberg J, Murphy MF, Staves J, Milkins C, Mercado TC, Illoh OC, Panzer S | 2013 | Vox Sang | View The use of the electronic (computer) cross-match | Blood operators | Benchmarking and standard setting |
Validation of sterility testing of cord blood: Challenges and results | Ramirez-Arcos S, Kou Y, Yang L, Perkins H, Taha M, Halpenny M, Elmoazzen H | 2015 | Transfusion | View Validation of sterility testing of cord blood: Challenges and results | Blood operators | New or improved product or process |
Development and evaluation of stem cell collection procedure diagrams to support the education and recruitment of committed stem cell donors | Fingrut W, Cuperfain AB, Chan SWS, Ptak E, Kahlon M, Dhaliwal J, Naidu A, Wang YG, Baribeau O, Mahmoudi T, Lee A, Suppiah R, Luo OD, Green M, Weiss JT, Mercer D, Elmoazzen H, Petraszko T, Allan D | 2020 | Vox Sang | View Development and evaluation of stem cell collection procedure diagrams to support the education and recruitment of committed stem cell donors | Blood operators | New or improved product or process |
International Forum on Walking Blood Bank Programmes: Responses | Martinaud C, Scorer T, Lozano M, Miles A, Fitchett G, Ba A, Wikman A, Nimberger-Hansson P, Enbuske S, Bohon?k M, Devine D, Beckett AN, Mbanya D, T'Sas F, Degueldre J, Chueca M, Dedome E, Apelseth T, Strandenes G, Wendel S, Fachini R, Olszewski A, Dupont C, Glassberg E, Shinar E, Taylor AL, Corley JB, Nadarajan VS, Dunbar N | 2021 | Vox Sang | View International Forum on Walking Blood Bank Programmes: Responses | Blood operators | New or improved product or process |
Impact of product platelet count reduction on platelet demand in Canada | Devine DV | 2022 | Transfusion | View Impact of product platelet count reduction on platelet demand in Canada | Blood operators | Benchmarking and standard setting |
Aggregates in platelet concentrates | van der Meer PF, Dumont LJ, Lozano M, Bondar N, Wong J, Ismay S, Pink J, Nussbaumer W, Coene J, Feys HB, Compernolle V, Devine DV, Howe D, Lin CK, Sun J, Ringwald J, Strasser EF, Eckstein R, Seltsam A, Perseghin P, Proserpio P, Wakamoto S, Akino M, Takamoto S, Tadokoro K, Teo D, Shu PH, Chua SS, Jimenez-Marco T, Lozano M, Cid J, Castro E, Munoz I, Gulliksson H, Sandgren P, Thomas S, Petrik J, McColl K, Kamel H, Dugger J, Sweeney JD, Gorlin JB, Sutor LJ, Heath D, Sayers MH | 2015 | Vox Sang | View Aggregates in platelet concentrates | Blood operators | Benchmarking and standard setting |
Deja-vu all over again: using simulation to evaluate the impact of shorter shelf life for red blood cells at Hema-Quebec | Blake JT, Hardy M, Delage G, Myhal G | 2013 | Transfusion | View Deja-vu all over again: using simulation to evaluate the impact of shorter shelf life for red blood cells at Hema-Quebec | Blood operators | New or improved product or process |
Implementation and public acceptability: lessons from food irradiation and how they might apply to pathogen reduction in blood products | Heddle NM, Lane SJ, Sholapur N, Arnold E, Newbold B, Eyles J, Webert KE | 2014 | Vox Sang | View Implementation and public acceptability: lessons from food irradiation and how they might apply to pathogen reduction in blood products | Blood operators | Other |
Seroprevalence of Babesia microti infection in Canadian blood donors | O'Brien SF, Delage G, Scalia V, Lindsay R, Bernier F, Dubuc S, Germain M, Pilot G, Yi Q-L, Fearon MA | 2016 | Transfusion | View Seroprevalence of Babesia microti infection in Canadian blood donors | Blood operators | New or improved product or process |
Vox Sanguinis international forum on platelet cryopreservation: summary | Cohn CS, Dumont LJ, Lozano M, Marks D, Johnson L, Ismay S, Bondar N, T'Sas F, Yokoyama APH, Kutner JM, Acker J, Bohonek M, Sailliol A, Martinaud C, Poglod R, Antoniewicz-Papis J, Lachert E, Pun P, Lu J, Cid J, Guijarro F, Puig L, Gerber B, Alberio L, Schanz U, Buser A, Noorman F, Zoodsma M, van der Meer PF, de Korte D, Wagner S, O'Neill M | 2017 | Vox Sang | View Vox Sanguinis international forum on platelet cryopreservation: summary | Blood operators | New or improved product or process |
Buffy coat platelets coming to America: Are we ready? | Gammon RR, Devine D, Katz LM, Quinley E, Wu Y, Rowe K, Razatos A, Min K, Reichenberg S, Smith R | 2021 | Transfusion | View Buffy coat platelets coming to America: Are we ready? | Blood operators | New or improved product or process |
Trans people and blood donation | Goldman M, Butler-Foster T, Lapierre D, O'Brien SF, Devor A | 2020 | Transfusion | View Trans people and blood donation | Blood operators | New or improved product or process |